Another group recently provided the first evidence reporting that APOC1 and TOMM40 polymorphisms might represent independent risk factors for developing AD, and its major variants are correlated with the disruption of biothiol metabolism and the insufficient removal of DNA oxidation [125]. This evidence concerns the gene APOC1 and Alzheimer disease.